Literature DB >> 21636068

Use of in-cycle antimüllerian hormone levels to predict cycle outcome.

Andrew S Blazar1, Geralyn Lambert-Messerlian, Richard Hackett, Stephan Krotz, Sandra A Carson, Jared C Robins.   

Abstract

OBJECTIVE: The goal of this work is to expand the usefulness of antimüllerian hormone (AMH) in predicting in vitro fertilization cycle outcome by demonstrating that AMH concentration obtained in an ongoing treatment cycle predicts both oocyte number and pregnancy. STUDY
DESIGN: Serum samples were obtained from 190 in vitro fertilization patients at onset of follicle-stimulating hormone stimulation. These were analyzed retrospectively during a single cycle in which clinicians were blinded to the results. Our major outcome measures were the number of oocytes obtained and ongoing pregnancy.
RESULTS: Patients with an initial AMH concentration of >3 ng/mL were found to produce a mean of 19.8 oocytes and had an ongoing pregnancy rate of 60.3%. In contrast, those with AMH values of ≤1 ng/mL yielded a mean of 6.2 oocytes and had an ongoing pregnancy rate of 23.4% (P < .0001 for both).
CONCLUSION: Greater AMH serum concentration strongly predicts an increased number of oocytes and ongoing pregnancy (P ≤ .0001).
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21636068     DOI: 10.1016/j.ajog.2011.04.035

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women.

Authors:  K A Kissell; M R Danaher; E F Schisterman; J Wactawski-Wende; K A Ahrens; K Schliep; N J Perkins; L Sjaarda; J Weck; S L Mumford
Journal:  Hum Reprod       Date:  2014-06-12       Impact factor: 6.918

2.  Anti-Müllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF.

Authors:  Pierre Lehmann; Maria P Vélez; Julio Saumet; Louise Lapensée; Wael Jamal; François Bissonnette; Simon Phillips; Isaac-Jacques Kadoch
Journal:  J Assist Reprod Genet       Date:  2014-02-27       Impact factor: 3.412

3.  Age effect on in vitro fertilization pregnancy mediated by anti-Mullerian hormone (AMH) and modified by follicle stimulating hormone (FSH).

Authors:  Han-Chih Hsieh; Jia-Ying Su; Shunping Wang; Yen-Tsung Huang
Journal:  BMC Pregnancy Childbirth       Date:  2020-04-09       Impact factor: 3.007

4.  Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle.

Authors:  Xin Liu; Ying Han; Xinyan Wang; Yunshan Zhang; Aijun Du; Ruqiang Yao; Jiabei Lv; Haining Luo
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-02       Impact factor: 3.105

5.  Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?

Authors:  Shunping Wang; Yi Zhang; Virginia Mensah; Warren J Huber; Yen-Tsung Huang; Ruben Alvero
Journal:  J Ovarian Res       Date:  2018-07-16       Impact factor: 4.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.